Terms: = Ovarian cancer AND FLT3, STK1, 2322, ENSG00000122025, P36888, FLK2, CD135, RP11-153M24_3 AND Diagnosis
5142 results:
1. Circular RNA circMAN1A2 promotes ovarian cancer progression through the microRNA-135a-3p/IL1RAP/TAK1 pathway.
Li B; Hu C; Zhao D; Nie M; Wang X
PeerJ; 2024; 12():e16967. PubMed ID: 38680890
[TBL] [Abstract] [Full Text] [Related]
2. High-Grade Serous ovarian cancer during Pregnancy: From diagnosis to Treatment.
Vivod G; Merlo S; Kovacevic N
Curr Oncol; 2024 Apr; 31(4):1920-1935. PubMed ID: 38668047
[TBL] [Abstract] [Full Text] [Related]
3. Exceptional lymph node recurrence of an unusual ovarian tumor 16 years later: a case report.
Sakhri S; Slimane M; Bouaziz H; Khessairi N; Boujelbene N; Ben Dhiab T
J Med Case Rep; 2024 Apr; 18(1):217. PubMed ID: 38654310
[TBL] [Abstract] [Full Text] [Related]
4. Granulosa cell tumor of the ovary: a series of 6 cases.
da Costa REAR; Silva MCA; Cavalcante ECX; Branco ROC; Dos Reis CA; Vieira SC
Pan Afr Med J; 2024; 47():58. PubMed ID: 38646138
[TBL] [Abstract] [Full Text] [Related]
5. Primary lymphoma of the female genital tract masquerading as gynecological malignancy.
Shi S; Li W; Ni G; Ding J; Liu Y; Wu H; Zhang Z; Ding Z
BMC Womens Health; 2024 Apr; 24(1):247. PubMed ID: 38637800
[TBL] [Abstract] [Full Text] [Related]
6. Rates of paclitaxel hypersensitivity reactions using a modified Markman's infusion protocol as primary prophylaxis.
Symons R; Heath F; Duggan J; Bui KT; Byun L; Friedlander M; Lee YC
Support Care Cancer; 2024 Apr; 32(5):292. PubMed ID: 38632132
[TBL] [Abstract] [Full Text] [Related]
7. Imaging for local recurrence of breast cancer.
Schlaiss T; Bott L; Herbert SL; Bartmann C; Kiesel M; Salmen J; Sauer ST; Christner SA; Petritsch B; Grunz JP; Woeckel A; Löb S; Diessner J
J Cancer Res Clin Oncol; 2024 Apr; 150(4):200. PubMed ID: 38627285
[TBL] [Abstract] [Full Text] [Related]
8. Construction and analysis of competitive endogenous RNA networks and prognostic models associated with ovarian cancer based on the exoRBase database.
Chen Z; Wang C; Ding J; Yu T; Li N; Ye C
PLoS One; 2024; 19(4):e0291149. PubMed ID: 38603733
[TBL] [Abstract] [Full Text] [Related]
9. Sensitive circulating tumor DNA-based residual disease detection in epithelial ovarian cancer.
Kallio HM; Savolainen K; Virtanen T; Ryyppö L; Selin H; Martikainen P; Staff S; Kivinummi K; Sipola J; Vuorinen J; Nikkola J; Nykter M; Auranen A; Annala M
Life Sci Alliance; 2024 Jun; 7(6):. PubMed ID: 38580393
[TBL] [Abstract] [Full Text] [Related]
10. Epithelial ovarian cancer in younger age versus older age groups: Survival and clinicopathological features.
Kongkamsuan W; Boonyapipat S
J Cancer Res Ther; 2024 Jan; 20(1):363-368. PubMed ID: 38554347
[TBL] [Abstract] [Full Text] [Related]
11. Evaluation of the Cutoff Point and Diagnostic Value of the Neutrophil-to-Lymphocyte Ratio in Predicting ovarian cancer Compared to Pathological Findings.
Hosseini MS; Amiri F; Rezapour M; Ashraf Ganjoie T; Farzaneh F; Arab M; Talayeh M; Beheshti Rooy R; Hadi F
Asian Pac J Cancer Prev; 2024 Mar; 25(3):971-976. PubMed ID: 38546079
[TBL] [Abstract] [Full Text] [Related]
12. [Clinical analysis of 12 cases of ovarian yolk sac tumor].
Liu J; Chu HJ; Shan YP; Song WJ; Chen AP
Zhonghua Fu Chan Ke Za Zhi; 2024 Mar; 59(3):210-214. PubMed ID: 38544450
[No Abstract] [Full Text] [Related]
13. Development and validation of an interpretable model integrating multimodal information for improving ovarian cancer diagnosis.
Xiang H; Xiao Y; Li F; Li C; Liu L; Deng T; Yan C; Zhou F; Wang X; Ou J; Lin Q; Hong R; Huang L; Luo L; Lin H; Lin X; Chen H
Nat Commun; 2024 Mar; 15(1):2681. PubMed ID: 38538600
[TBL] [Abstract] [Full Text] [Related]
14. Accuracy of endometrial sampling in the diagnosis of endometrial cancer: a multicenter retrospective analysis of the JAGO-NOGGO.
Alwafai Z; Beck MH; Fazeli S; Gürtler K; Kunz C; Singhartinger J; Trojnarska D; Zocholl D; Krankenberg DJ; Blohmer JU; Sehouli J; Pietzner K
BMC Cancer; 2024 Mar; 24(1):380. PubMed ID: 38528468
[TBL] [Abstract] [Full Text] [Related]
15. PURE vs. mixed clear cell ovarian carcinomas: Is there any impact on survival?
Güzel D; Terek C; Besler A; Serin G; Önal Z; Akman L; Göker E; Ali Şanli U; Zekioğlu O; Özdemir N; Özsaran A; Yildirim N
Eur J Obstet Gynecol Reprod Biol; 2024 May; 296():321-326. PubMed ID: 38518487
[TBL] [Abstract] [Full Text] [Related]
16. A comparison of the clinical and histological appearances after treatment of advanced stage ovarian cancer with PlasmaJet® device.
Natarajan P; Martha Schofield A; Elena Vinturache A; Ruthven S; Lane S; Duncan Macdonald R
Eur J Obstet Gynecol Reprod Biol; 2024 May; 296():311-315. PubMed ID: 38518485
[TBL] [Abstract] [Full Text] [Related]
17. Clinicopathological features and surgical procedures of adnexal masses with abdominal pain in pediatric and adolescent patients.
Liu Q; Li Z; Zhou H; Cao D; Yang J; Shen K; Lang J
Orphanet J Rare Dis; 2024 Mar; 19(1):132. PubMed ID: 38515195
[TBL] [Abstract] [Full Text] [Related]
18. Association of tet methylcytosine dioxygenase 2 and 5-hydroxymethylcytosine in endometrioid adenocarcinoma and its clinical significance.
Kuang L; Zhang J; Li Y; Wang Q; Liu J; Zhang B
BMC Womens Health; 2024 Mar; 24(1):188. PubMed ID: 38515066
[TBL] [Abstract] [Full Text] [Related]
19. Ewing sarcoma of the cervix: an unusual site of presentation.
Hernández-García JG; Pinto García LJ; Marché Fernández OA; Diaz-Garcia JD
BMJ Case Rep; 2024 Mar; 17(3):. PubMed ID: 38514153
[TBL] [Abstract] [Full Text] [Related]
20. diagnosis Shift in Site of Origin of Tubo-ovarian Carcinoma.
Lee MW; Anderson ZS; Girma AM; Klar M; Roman LD; Carlson JW; Wright JD; Sood AK; Matsuo K
Obstet Gynecol; 2024 May; 143(5):660-669. PubMed ID: 38513238
[TBL] [Abstract] [Full Text] [Related]
[Next]